Eloïse Marques

Eloïse Marques

Auto-generated profile, based on publicly available information

Eloïse Marques

MRC Mitochondrial Biology Unit, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2025 in Nature Communications
Verified
Journal Article
Open access
EMEloïse Marques
Eloïse Marques
SBStephen P. Burr
Stephen P. Burr
ACAlva M. Casey
Alva M. Casey
RSRichard J. Stopforth
Richard J. Stopforth
CYChak Shun Yu
Chak Shun Yu
DRDylan G. Ryan
Dylan G. Ryan
Impaired mitochondrial bioenergetics in macrophages promotes hyperinflammatory cytokine responses, but whether inherited mtDNA mutations drive similar phenotypes is unknown. Here, we profiled macrophages harbouring a heteroplasmic mitochondrial tRNA Ala mutation ( m.5019A > G ) to address this question. These macrophages exhibit combined respiratory chain defects, reduced oxidative phosphorylation, disrupted cristae architecture, and compensatory metabolic adaptations in central carbon metabolism. Upon inflammatory activation, m.5019A > G macrophages produce elevated type I interferon (IFN), while exhibiting reduced pro-inflammatory cytokines and oxylipins. Mechanistically, suppression of pro-IL-1β and COX2 requires autocrine IFN-β signalling. IFN-β induction is biphasic: an early TLR4-IRF3 driven phase, and a later response involving mitochondrial nucleic acids and the cGAS-STING pathway. In vivo, lipopolysaccharide (LPS) challenge of m.5019A > G mice results in elevated type I IFN signalling and exacerbated sickness behaviour. These findings reveal that a pathogenic mtDNA mutation promotes an imbalanced innate immune response, which has potential implications for the progression of pathology in mtDNA disease patients.

19 December 2025 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
EMEloïse Marques
Eloïse Marques
MTMaraiza Alves Teixeira
Maraiza Alves Teixeira
CPCorentin Ramauge Parra
Corentin Ramauge Parra
PIPierre Isnard
Pierre Isnard
MKMairead Kelly-Aubert
Mairead Kelly-Aubert
MGMorgan Gallazzini
Morgan Gallazzini
Key Points: Lipocalin-2 inhibited clustered mitochondrial homolog (CLUH) activity and caused mitochondrial dysfunction. Loss of CLUH in kidneys triggered metabolic reprogramming and impaired mitochondrial structure. CLUH expression decreased with kidney injury and correlated with kidney function decline in patients. Background: Lipocalin-2 (LCN2) is a secreted protein involved in transporting hydrophobic molecules, regulating antibacterial responses and iron homeostasis. LCN2 expression increases after kidney damage and participates in CKD onset. We previously identified LCN2 as a regulator of mitochondrial dysfunction in renal tubular cells. This study aims to better understand LCN2's role in mitochondrial dysfunction and kidney pathology. Methods: LCN2 interactome was studied using mass spectrometry. The impact of LCN2 on clustered mitochondrial homolog (CLUH) activity was explored by immunofluorescence, Western blot, quantitative PCR, and RNA-immunoprecipitation. The role of CLUH on mitochondrial function in kidney was evaluated by RNAseq, metabolomics, electron microscopy, and immunochemistry using transgenic mice. Results: We characterized LCN2 interactome and identified CLUH in a multiprotein complex with LCN2. CLUH regulates mitochondrial homeostasis by binding mRNAs of nuclear-encoded mitochondrial proteins and promoting their translation. We demonstrated that LCN2 inhibited CLUH activity, leading to perinuclear mitochondrial clustering. We showed that CLUH was expressed in renal tubular cells and that its expression and activity decreased, while LCN2 expression increased after kidney injury leading to CKD. In human CKD patients, CLUH expression was inversely correlated with kidney lesions and kidney failure. CLUH genetic deletion in kidney nephron induced mitochondrial dysfunction and a subsequent interstitial fibrosis and kidney loss of function. Conclusions: This study shows that LCN2 forms a complex with CLUH and inhibits its activity, leading to perinuclear mitochondrial clustering. CLUH loss of function in renal tubular cells is associated with mitochondrial dysfunction and fibrosis, and in humans, CLUH expression inversely correlates with kidney lesions and loss of function.

5 January 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
EMEloïse Marques
Eloïse Marques
SBStephen P. Burr
Stephen P. Burr
ACAlva M. Casey
Alva M. Casey
RSRichard J. Stopforth
Richard J. Stopforth
CYChak Shun Yu
Chak Shun Yu
DRDylan Gerard Ryan
Dylan Gerard Ryan
Impaired mitochondrial bioenergetics in macrophages can drive hyperinflammatory cytokine responses 1–6 , but whether this may also be caused by inherited mtDNA mutations is unknown. Here, we address this question using a multi-omic approach that integrates super-resolution imaging and metabolic analyses to profile macrophages from a mouse model of mitochondrial disease arising from a heteroplasmic mutation (m.5019A>G) in the mitochondrial tRNA for alanine 7 . These m.5019A>G macrophages exhibit defects in respiratory chain complexes and oxidative phosphorylation (OxPhos) due to decreased intra-mitochondrial translation. To adapt to this metabolic stress, mitochondrial fusion, reductive glutamine metabolism, and aerobic glycolysis are all increased. Upon inflammatory activation, type I interferon (IFN-I) release is enhanced, while the production of pro-inflammatory cytokines and oxylipins are restrained in m.5019A>G macrophages. Finally, an in vivo endotoxemia model using m.5019A>G mice reveal elevated IFN-I levels and sickness behaviour. In conclusion, our study identifies an unexpected imbalance in innate immune signalling in response to a pathogenic mtDNA mutation, with important implications for the progression of pathology in patients with mtDNA diseases 8 .

7 April 2026
Verified
Thesis
Closed access
EMEloïsE Marques
EloïsE Marques
Il est largement connu qu'au cours de la maladie rénale chronique (MRC), une perte de la masse et de la fonction mitochondriale conduisent à la production d'espèces réactives de l'oxygène (ROS) et à la mise en place de l'apoptose des cellules tubulaires rénales. Ainsi, la dysfonction mitochondriale participe à la progression de la MRC. Cependant, les mécanismes cellulaires induisant cette dysfonction dans les cellules rénales ne sont pas complètement élucidés. D'autre part, notre équipe a récemment démontré que l'expression de la Lipocaline-2 (Lcn2), une protéine sécrétée de 25kDa, est fortement induite dans les cellules rénales. Cette synthèse de Lcn2 va augmenter la production de ROS intracellulaires et induire l'apoptose des cellules tubulaires rénales, conduisant à la mise en place de la MRC. Néanmoins, les mécanismes par lesquels Lcn2 induit ces phénomènes ne sont pas connus. Considérant le rôle des mitochondries dans la genèse des ROS et l'apoptose cellulaire, nous avons alors émis l'hypothèse que la Lipocaline-2 participerait à la mise en place de la MRC via l'induction de dysfonctions mitochondriales. L'utilisation de lignées de cellules tubulaires rénales surexprimant ou invalidées pour l'expression de Lcn2 nous a permis d'étudier l'effet de l'expression de Lcn2 sur la fonction et la dynamique mitochondriale. Tout d'abord, nous avons démontré que Lcn2 régule la dynamique, la masse ainsi que la fonction des mitochondries. Par ailleurs, l'effet de la Lipocaline-2 semble être indépendant de son effet de transport de fer ou de production de ROS. De plus, mes travaux démontrent que l'effet de Lcn2 sur les mitochondries ne se fait par via sa forme sécrétée. L'étude de l'interactome de la Lipocaline-2 a mis en évidence Clustered Mitochondria Homolog (CLUH), une protéine importante dans l'homéostasie mitochondriale, comme interagissant avec Lcn2. De façon intéressante, nous observons que l'expression de Lcn2 dans les cellules inhibe l'activité de CLUH, induisant une dysfonction mitochondriale. Enfin, la seconde partie de mes travaux permet de démontrer les mécanismes moléculaires par lesquels Lcn2 régule la fission mitochondriale. En effet, des expériences de mutations dirigées de la protéine Lcn2 démontrent que sa phosphorylation est nécessaire à l'effet de Lcn2 sur la fission mitochondriale. De plus, je mets en évidence le rôle probable de la voie mTOR dans la signalisation induite par Lcn2 menant à la fission des mitochondries.

4 August 2025 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
EMEloïse Marques
Eloïse Marques
DRDylan G. Ryan
Dylan G. Ryan